Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-06

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Rizatriptan Benzoate by Teva Pharmaceuticals USA, Inc., approving an updated indication/label for this migraine trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)